People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head ... Press Health and Science Department receives ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head ... Press Health and Science Department receives ...

according to a new report by the World Health Organization. The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its vaccine center ...

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is ...

In April, the Trump administration disbanded a Justice Department unit dedicated to ... of the bill focus on making cuts to Medicaid, the health care program for the poor, and food stamps, all ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study ... The Associated Press Health and Science ...

Britain’s most senior statistician has stepped down citing “ongoing health issues”, amid criticism over flaws in recent economic data. Sir Ian Diamond confirmed he has resigned as head of the Office ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.